Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | GAA | P10253 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 1/20 | 0.66 |
| ▸ | CASP1 | P29466 | 1/20 | 0.66 |
| ▸ | CASP7 | P55210 | 1/20 | 0.66 |
| ▸ | EGFR | P00533 | 5/20 | 0.64 |
| ▸ | SRC | P12931 | 2/20 | 0.49 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4975424 | 1.00 | KDM4E (0.66) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL7964387 | 0.85 | KDM4E (0.53) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL28190374 | 0.81 | EGFR (0.68) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL6824403 | 0.81 | KDM4E (0.59) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL29470940 | 0.81 | KDM4E (0.68) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL5211637 | 0.81 | ALDH1A1 (0.68) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL4468686 | 0.81 | KDM4E (0.68) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL152237 | 0.79 | KDM4E (0.66) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL5063952 | 0.79 | ALDH1A1 (0.66) | KDM4EALDH1A1GAAMAPTCASP1 | |
| SCHEMBL379103 | 0.79 | KDM4E (1.00) | KDM4EALDH1A1GAAMAPTCASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12507648-B2 | Methods and compositions for rapid plant transformation | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250324934-A1 | METHODS AND COMPOSITIONS FOR RAPID PLANT TRANSFORMATION | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2025-10-23 | — | — | US | disclosed |
| CN-108368517-B | Methods and compositions for rapid plant transformation | 先锋国际良种公司 | 2022-08-02 | — | — | CN | disclosed |
| US-11330776-B2 | Methods and compositions for rapid plant transformation | PIONEER HI-BRED INTERNATIONAL, INC. | 2022-05-17 | — | — | US | disclosed |
| US-20220124998-A1 | METHODS AND COMPOSITIONS FOR RAPID PLANT TRANSFORMATION | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2022-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507648-B2 | Methods and compositions for rapid plant transformation | POF1B, IWS1, CCNH | KDM4E 4595/4885ALDH1A1 4180/4885GAA 3694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.